This article is part of the network’s archive of useful research information. This article is closed to new comments due to inactivity. We welcome new content which can be done by submitting an article for review or take part in discussions in an open topic or submit a blog post to take your discussions online.
This study examined the risks of adverse perinatal outcomes associated with antidepressant use during pregnancy. Both depression and antidepressant use were independently associated with the risk of adverse perinatal outcomes; however, the risk associated with antidepressants was higher over and above the risk associated with depression. This may reflect the biological effects of antidepressants, greater severity of depression in those treated, or both.
References
Lynch MM, Squiers LB, Kosa KM, et al. Making decisions about medication use during pregnancy: Implications for communication strategies. Matern Child Health J. 2018;22(1):92‐100.
Cantarutti A, Merlino L, Giaquinto C, Corrao G. Use of antidepressant medication in pregnancy and adverse neonatal outcomes: A population‐based investigation. Pharmacoepidemiol Drug Saf. 2017;26(9):1100‐8
Norby U, Forsberg L, Sjors G, Wide K, Winbladh B, Kallen K. Neonatal morbidity after maternal use of antidepressant drugs during pregnancy. Pediatrics. 2016;138(5):e20160181.